Literature DB >> 21696723

Chondrocytes or adult stem cells for cartilage repair: the indisputable role of growth factors.

Anne-Marie Freyria1, Frédéric Mallein-Gerin.   

Abstract

Articular cartilage is easily injured but difficult to repair and cell therapies are proposed as tools to regenerate the defects in the tissue. Both differentiated chondrocytes and adult mesenchymal stem cells (MSCs) are regarded as cells potentially able to restore a functional cartilage. However, it is a complex process from the cell level to the tissue end product, during which growth factors play important roles from cell proliferation, extracellular matrix synthesis, maintenance of the phenotype to induction of MSCs towards chondrogenesis. Members of the TGF-β superfamily, are especially important in fulfilling these roles. Depending on the cell type chosen to restore cartilage, the effect of growth factors will vary. In this review, the roles of these factors in the maintenance of the chondrocyte phenotype are discussed and compared with those of factors involved in the repair of cartilage defects, using chondrocytes or adult mesenchymal stem cells. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21696723     DOI: 10.1016/j.injury.2011.05.035

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  50 in total

1.  B2A peptide induces chondrogenic differentiation in vitro and enhances cartilage repair in rats.

Authors:  Xinhua Lin; Shobana Shanmugasundaram; Yi Liu; Alexandrine Derrien; Maria Nurminskaya; Paul O Zamora
Journal:  J Orthop Res       Date:  2012-01-23       Impact factor: 3.494

2.  Physical Stimulations for Bone and Cartilage Regeneration.

Authors:  Xiaobin Huang; Ritopa Das; Avi Patel; Thanh Duc Nguyen
Journal:  Regen Eng Transl Med       Date:  2018-06-25

3.  The state of cartilage regeneration: current and future technologies.

Authors:  Adam B Yanke; Susan Chubinskaya
Journal:  Curr Rev Musculoskelet Med       Date:  2015-03

Review 4.  Strategies for controlled delivery of biologics for cartilage repair.

Authors:  Johnny Lam; Steven Lu; F Kurtis Kasper; Antonios G Mikos
Journal:  Adv Drug Deliv Rev       Date:  2014-06-30       Impact factor: 15.470

5.  A microRNA signature associated with chondrogenic lineage commitment.

Authors:  Behnaz Bakhshandeh; Masoud Soleimani; Seyed Hassan Paylakhi; Nasser Ghaemi
Journal:  J Genet       Date:  2012-08       Impact factor: 1.166

Review 6.  Controlled release strategies for bone, cartilage, and osteochondral engineering--Part I: recapitulation of native tissue healing and variables for the design of delivery systems.

Authors:  Vítor E Santo; Manuela E Gomes; João F Mano; Rui L Reis
Journal:  Tissue Eng Part B Rev       Date:  2013-02-19       Impact factor: 6.389

7.  Articular chondrocyte redifferentiation in 3D co-cultures with mesenchymal stem cells.

Authors:  Ville V Meretoja; Rebecca L Dahlin; Sarah Wright; F Kurtis Kasper; Antonios G Mikos
Journal:  Tissue Eng Part C Methods       Date:  2014-01-04       Impact factor: 3.056

8.  Poly(γ-Glutamic Acid) as an Exogenous Promoter of Chondrogenic Differentiation of Human Mesenchymal Stem/Stromal Cells.

Authors:  Joana C Antunes; Roman Tsaryk; Raquel M Gonçalves; Catarina Leite Pereira; Constantin Landes; Christoph Brochhausen; Shahram Ghanaati; Mário A Barbosa; C James Kirkpatrick
Journal:  Tissue Eng Part A       Date:  2015-04-30       Impact factor: 3.845

9.  The effect of hypoxia on the chondrogenic differentiation of co-cultured articular chondrocytes and mesenchymal stem cells in scaffolds.

Authors:  Ville V Meretoja; Rebecca L Dahlin; Sarah Wright; F Kurtis Kasper; Antonios G Mikos
Journal:  Biomaterials       Date:  2013-03-13       Impact factor: 12.479

10.  FGF-2 addition during expansion of human bone marrow-derived stromal cells alters MSC surface marker distribution and chondrogenic differentiation potential.

Authors:  S Hagmann; B Moradi; S Frank; T Dreher; P W Kämmerer; W Richter; T Gotterbarm
Journal:  Cell Prolif       Date:  2013-08       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.